The Role of Estrogen Hormone In Menstrual Cycle As A Trigger Factor For Migraine
DOI:
https://doi.org/10.53089/medula.v10i2.71Keywords:
Estrogen withdrawal, menstrual cycle, migraineAbstract
Migraine is a recurrent attacks of headache with signs and symptoms such as nausea, vomiting, photophobia, and phonophobia. Migraine is divided into two subtypes, migraine without aura and migraine with aura. Prevalence of migraine is increase in women after puberty and more than 50% the attack occurs on menstruation. Migrain can be triggered by many factors, such as age, gender, psychologic factors, and the more important is hormonal factor on menstrual cycle, oral contraceptive used, pregnancy, and menopause. However, the menstruation is a significant risk factor in triggering the incidence of migraine without aura. The menstrual cycle consists of three phases, that are the follicular phase, ovulation, and the luteal phase. In the menstrual cycle, there is an important theory that can explain the occurs of menstrual migraine, that is estrogen withdrawal theory that developed by Somerville. The risk of migraine without aura will increase on two days before the menstruation begin until three days of menstruation. This matter is related to estrogen withdrawal or a big decline of estrogen hormone on early follicular phase and late luteal phase. In the presence of estrogen withdrawal, there will be a supressed of serotonergic system and a delayed recovery from the glutamatergic system on central nervous system. The estrogen withdrawal in menstrual cycle which facilitated these neurotransmitter system has a role in triggering the migraine without aura.
References
Cibian AP, Pereira LD. Temporal resolution hearing in menstrual migraine. Rev. CEFAC. 2014;16(3):747-756.
Vetvik KG. Menstrual migraine in the general population -prevalence , clinical characteristics and classification [disertasi]. Oslo: University of Oslo; 2014.
Ferreira K dos S, Bolinelli LP, Pagotto LC. Migraine and menstrual cycle synchrony in females: is there a relationship? Case report. Rev Dor. 2015;16(2):156-8.
Faubion SS, Casey PM, Shuster LT. Hormonal contraception and migraine:clinical considerations. Curr Pain Headache Rep. 2012;16:461-6.
Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis - part 2. Headache. 2006;46:365-386.
Hamilton KJ, Arao Y, Korach KS. Estrogen hormone physiology: Reproductive findings from estrogen receptor mutant mice. Reprod Biol. 2014;14(1):3-8.
Çiftci HB. Estrogen and growth hormone and their roles in reproductive function. Int J Anim Vet Adv. 2013;5(1):21-28.
Green MW. Headache & facial pain. Dalam: Brust JCM, editor. Current diagnosis & treatment neurology. Edisi ke-2. New York: McGraw-Hill Medical; 2012:63-77.
Riyadina W, Turana Y. Faktor risiko dan komorbiditas migrain. Buletin Penelitian Sistem Kesehatan. 2014;17(4):371-8.
Utami MN, Oktarlina RZ, Himayani R. Korelasi antara migrain dengan kejadian stroke. Medula. 2017;7(4):42-6.
International Headache Society. Thenternational Classification of Headache Disorders, 3rd edition (beta version). Cephalgia. 2013;33(9):629-808.
MacGregor EA. Migraine management during menstruation and menopause. Continuum. 2015;21(4):990-1003.
MacGregor A. Menstrual migraine : the role of oestrogen [tesis]. London: Universiity of London; 2008.
Reed BG, Carr BR. The normal menstrual cycle and the control of ovulation. Dalam: DeGroot L, Dungan K, Chrousos G, Kaltsas G, Rebar R, Feingold K, Dkk, editor. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2018 [diperbarui tanggal 5 Agustus 2018; disitasi tanggal 13 November 2018]. Tersedia dari: https://www.ncbi.nlm.nih.gov/books/NBK279054/
Dhillon KS, Singh J, Lyall JS. A new horizon into the pathobiology, etiology and treatment of migraine. Med Hypotheses. 2011;77(1):147-151
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 MEDULA
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.